Trial intelligence / Profile preview

Vitamin D Replacement Therapy in Black and West African Men Diagnosed With Prostate Cancer

NCT07598032Phase 3Not yet recruiting

Sponsor
University of Ilorin Teaching Hospital
Start
Jun 2026
Primary completion
Jun 2028
Modality
Orthosteric Ligands, Metabolically Activated Prodrugs
Countries
1
01

Overview

A Phase 3 trial of vitamin d in prostate cancer (PCa), sponsored by University of Ilorin Teaching Hospital. Planned start Jun 2026; status: not yet recruiting.

02

Drugs

vitamin d
03

Conditions

prostate cancer (PCa)

Beyond the preview

Go deeper on NCT07598032.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07598032.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call